The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anaemic patients with chronic kidney disease not on renal replacement therapy.

Official Title

Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease.


  • Chronic Kidney Failure

Study Type


Study Design

Treatment, Randomised, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study.

Further Details

Study Start

March 2004

Eligibility & Criteria

  • Ages Eligible for Study: 18 years and older
  • Genders Eligible for Study:



Inclusion Criteria:

  • Chronic kidney disease
  • Anaemia (Hb 8 – 11.5 g/dl)
  • Age above 18 years
  • Signed informed consent

Exclusion Criteria:

  • Rapid progression of kidney disease
  • Need for dialysis
  • Uncontrolled hypertension

Total Enrolment


Contact Details


Roland M Schaefer, MD


University Hospital Muenster


Westphalia University Hospital Muenster 
Muenster, Westphalia,
Germany, 48149